Intellectual Property UK

  • May 08, 2024

    3D Printer Co. Can't Fix Patent Jam On Appeal

    An Italian maker of 3D printers failed to prove previous examiners had made "fundamental" procedural errors when they revoked one of its patents.

  • May 08, 2024

    UKIPO Builds AI Patent Ruling Into New Guidance

    The U.K. Intellectual Property Office has published new guidance on patent applications adopting recent case law developments on artificial intelligence-related inventions into the agency's patent evaluation process, including a decision that artificial neural networks shouldn't be treated as unpatentable software.

  • May 08, 2024

    Puma Can't Trip Up Rival Shoe Designs IP

    Puma failed Wednesday to convince a European court that two rivals' sneaker designs had soles that were too similar to its own to gain design protections after the court concluded that it had to consider the shoes as a whole.

  • May 08, 2024

    Daimler Loses Bid For 'Certified' Trademark At EU Court

    Auto giant Daimler lost its bid on Wednesday for trademark registration over a logo bearing the word "certified" as a European Union court found that the word had no distinctive meaning in connection with trucks.

  • May 08, 2024

    Dr. Martens Accuses Temu Of Google Search TM Use

    Dr. Martens has accused Chinese ultra-fast fashion giant Temu of paying Google to show its knockoffs of the British shoemaker's famous black boots in the search results of online shoppers.

  • May 07, 2024

    Mexican Media Co. Nixes Crypto Rival's 'Aztec' TM

    Televisión Azteca successfully blocked a cryptocurrency software firm's trademark application for "Aztec," after British officials ruled that consumers might think the TV provider was promoting educational programs about digital coins.

  • May 07, 2024

    Doctor Wins Battle For 'Skinly' TM Against Cosmetics Co.

    A Swiss dermatologist won his fight to get trademark protection for "Skinly," when appellate officials at the European Union Intellectual Property Office tossed a lower division's finding that consumers would mistake the mark for a rival skin care brand.

  • May 07, 2024

    Moderna Says Pledge Didn't Waive COVID Vaccine Patent Rights

    Moderna and Pfizer questioned expert witnesses on U.S. federal law on Tuesday in their London court battle over whether Moderna is bound by its pledge not to enforce its COVID-19 vaccine patent rights against those making vaccines to combat the virus during the pandemic.

  • May 07, 2024

    Iceland Supermarket Hit With Kebab Co.'s TM Claim

    A kebab meat supplier has accused frozen food supermarket Iceland of using the trademark for its logo on several of its food items, even after the company stopped supplying the shop with its own products.

  • May 07, 2024

    Online Retailers Tap AI In Fight Against Counterfeiting

    Reviews are vital for online shopping, but fake posts have become a cottage industry for fraudsters. However, websites are fighting back, often using the same artificial intelligence tools deployed by scammers.

  • May 07, 2024

    Regeneron Hit With Eye Medicine Patent Challenge In UK

    A biosimilars specialist and its licensing partner have challenged the validity of Regeneron's U.K. eye medicine patents amid their plans to market an alternative version, telling a London court that the medicine lacks inventiveness and is not worthy of protection.

  • May 03, 2024

    California Denim Brand Can't Get Rival 'Paige' TM Canceled

    California clothing brand PAIGE has failed to convince the U.K. Intellectual Property Office to scrap a Yorkshire clothing brand's "Paige & Partridge" trademark, with officials finding that consumers would not think the mark signifies a collaboration between the two companies.

  • May 03, 2024

    UK Litigation Roundup: Here's What You Missed In London

    The past week in London has seen rapper Ivorian Doll hit with a copyright claim, private members club Aspinalls file a claim against a Saudi sheikh, and Motorola Solutions file a claim against the British government on the heels of its dispute over losing a £400 million ($502 million) government contract. Here, Law360 looks at these and other new claims in the U.K.

  • May 03, 2024

    Arts Charity Sues Over Queen's Holographic Portrait

    An arts charity has sued an artist for infringing the copyright it owns in a series of portraits it commissioned of the queen, claiming that he owes the organization £100,000 ($125,500) and substantial fees from unlicensed sales.

  • May 03, 2024

    'Gel Works' Too Laudatory For TM Despite Other Similar Logos

    An Australian lubricant maker has failed to register a trademark over its name, "Gel Works," after European officials ruled that the sign told consumers a lot about the lube quality — but not much about the company making it.

  • May 03, 2024

    5 Questions For Mewburn Ellis TM Chief Andy King

    Mewburn Ellis LLP head of trademark Andy King talks to Law360 about changing client attitudes, keeping pace with rapidly evolving technology, such as the twin impacts of artificial intelligence and virtual reality, plus the fight for effective representation at the U.K. trademark office.

  • May 02, 2024

    McNeil Again Denied Patent On Spray Nicotine Treatment

    A Kenvue-owned pharmaceutical company has failed to patent a tobacco replacement therapy, after European patent officials ruled that other scientists would have thought of adding a special solution to counteract the slowing effects of saliva pH.

  • May 02, 2024

    IBM Director Grilled Over Reverse Engineering Allegations

    An IBM director faced questions on Thursday about his role in accusing a tech rival of breaching its customer agreement by claiming it reverse-engineered IBM software, with lawyers for the rival arguing he improperly terminated the customer contract.

  • May 02, 2024

    InterDigital Claims Munich Court Win In Lenovo SEP Spat

    InterDigital said Thursday it has secured an injunction against Lenovo in Germany, with a Munich court ruling that Lenovo infringed an InterDigital patent deemed essential to 4G and 5G technology and was unwilling to agree to a fair license.

  • May 02, 2024

    Truck Aerodynamics Co. Sues Over Amazon Deal Loss

    A truck aerodynamics company has accused a rival of modifying products that were being tested by Amazon, leading them to perform poorly and causing the company to lose out on a million-pound contract.

  • May 02, 2024

    Universal Music Allows Artists Back On TikTok After Deal

    Universal Music Group has reached a deal with TikTok that will allow its affiliated artists and music to return to the social media platform months after the companies fell out over issues of artist compensation and artificial intelligence-generated content.

  • May 02, 2024

    Bayer Sues Dr. Reddy's In Latest Xarelto Patent Clash

    Bayer has accused generic drugmaker Dr. Reddy's of selling blood thinning medication that infringes a dosage patent over its blockbuster drug Xarelto, marking the latest attempt by the pharmaceutical giant to stop challenges to its market share.

  • May 01, 2024

    Abbott Wants Sales Of Rival Glucose Monitor Barred For Now

    A subsidiary of Abbott Laboratories urged a London court Wednesday to bar medical devices rival Sinocare Inc. from mass marketing a glucose monitoring system that it argues is highly similar to a trademark for one of its own products.

  • May 01, 2024

    Bayer Gets Chance To Appeal Xarelto Patent Loss

    Bayer AG can appeal a High Court decision that nixed a patent for its blockbuster drug Xarelto in the U.K., the U.K. judiciary confirmed on Wednesday.

  • May 01, 2024

    10x Genomics Gets Injunction Against Rival's DNA Kit

    Curio Bioscience must immediately stop selling a version of its spatial mapping kits used for DNA and RNA analysis of tissue samples, after the Unified Patent Court ruled they might be infringing on 10x Genomics' patent.

Expert Analysis

  • English Could Be The Future Language Of The UPC

    Author Photo

    While most Unified Patent Court proceedings are currently held in German, the recent decisions in Plant-e v. Arkyne and Amgen v. Sanofi potentially signal that English will be the preferred language, particularly in cases involving small and medium enterprises, say lawyers at Freshfields.

  • Arbitration Remains Attractive For Digital Disputes In 2024

    Author Photo

    Recent regulatory and digital forum developments highlight that, in 2024, arbitration will continue to adapt to new technologies, such as artificial intelligence and cryptocurrency, and remain an attractive forum for resolving digital disputes due to its flexibility, confidentiality and comparative ease to enforce cross-border awards, says Peter Smith at Charles Russell.

  • US And UK Law Firms Continue Trend Of EU Expansion

    Author Photo

    A broad spectrum of U.S. and U.K. law firms are now seeking fresh opportunities in Europe's fastest growing and constantly evolving sectors by opening offices in strategic locations across the continent, says James Lavan at Buchanan Law.

  • Looking Ahead At AI Regulation In The EU And UK

    Author Photo

    With AI regulation agreed upon in Europe and a U.K. regulatory authority on the horizon, organizations developing AI should consider deploying governance, addressing accountability and establishing internal guardrails to achieve a balanced approach to responsible innovation while managing risk, says Chris Eastham at Fieldfisher.

  • 2024 Will Be A Busy Year For Generative AI And IP Issues

    Author Photo

    In light of increased litigation and policy proposals on balancing intellectual property rights and artificial intelligence innovation, 2024 is shaping up to be full of fast-moving developments that will have significant implications for AI tool developers, users of such tools and rights holders, say lawyers at Mishcon de Reya.

  • The Most-Read Law360 UK Guest Articles Of 2023

    Author Photo

    Benefits of the new EU Unified Patent Court, artificial intelligence regulation and M&A trends amid rising inflation were among the hot topics U.K. Expert Analysis articles explored this year.

  • 9 Takeaways From The UPC's First 6 Months In Session

    Author Photo

    Six months after its opening, the Unified Patent Court has established itself as an appealing jurisdiction, with its far territorial reach, short filing deadlines and extremely quick issuance of preliminary injunctions showing that it is well-prepared to provide for rapid legal clarity, says Antje Brambrink at Finnegan.

  • The Year In FRAND: What To Know Heading Into 2024

    Author Photo

    In 2023, there were eight significant developments concerning the fair, reasonable and nondiscriminatory patent licensing regime that undergirds technical standardization, say Tom Millikan and Kevin Zeck at Perkins Coie.

  • How Int'l Student-Athlete Law Would Change The NIL Game

    Author Photo

    Recently proposed legislation to allow international student-athletes the opportunity to profit from their name, image and likeness without violating their F-1 nonimmigrant student visa status represents a pivotal step in NIL policy, and universities must assess and adapt their approaches to accommodate unique immigration concerns, say attorneys at Phelps Dunbar.

  • Series

    Children's Book Writing Makes Me A Better Lawyer

    Author Photo

    Becoming a children's book author has opened doors to incredible new experiences of which I barely dared to dream, but the process has also changed my life by serving as a reminder that strong writing, networking and public speaking skills are hugely beneficial to a legal career, says Shaunna Bailey at Sheppard Mullin.

  • How The PTAB Landscape Shifted In 2023

    Author Photo

    Attorneys at Finnegan consider the impact of noteworthy Patent Trial and Appeal Board developments in 2023, including rulemaking, litigation, precedential decisions and director reviews that affected PTAB practice, and offer a reference for examining future proceedings and strategies.

  • How 'Copyleft' Licenses May Affect Generative AI Output

    Author Photo

    Open-source software and the copyleft licenses that support it, whereby derivative works must be made available for others to use and modify, have been a boon to the development of artificial intelligence, but could lead to issues for coders who use AI to help write code and may find their resulting work exposed, says William Dearn at HLK.

  • UPC Decision Highlights Key Security Costs Questions

    Author Photo

    While the Unified Patent Court recently ordered NanoString to pay €300,000 as security for Harvard's legal costs in a revocation action dispute, the decision highlights that the outcome of a security for costs application will be highly fact-dependent and that respondents should prepare to set out their financial position in detail, says Tom Brazier at EIP.

  • IP Ruling Could Pave Way For AI Patents In UK

    Author Photo

    If implemented by the U.K. Intellectual Property Office, the High Court's recent ruling in Emotional Perception AI v. Comptroller-General of Patents, holding that artificial neural networks can be patented, could be a first step to welcoming AI patents in the U.K., say Arnie Francis and Alexandra Brodie at Gowling.

  • Why It's Urgent For Pharma Cos. To Halt Counterfeit Meds

    Author Photo

    With over 10.5 million counterfeit medicines seized in the EU in 2023, it is vital both ethically and commercially that pharmaceutical companies take steps to protect against such infringements, including by invoking intellectual property rights protection, says Lars Karnøe at Potter Clarkson.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property UK archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!